EUVIMEDEUVIMED entdecken
Crossref

Tricuspid intervention for less-than-severe regurgitation simultaneously with minimally invasive mitral valve surgery in patients with atrial fibrillation

Mariusz Kowalewski, Emil Julian Dąbrowski, Łukasz Kuźma, Marek Jasiński, Michał Pasierski, Kazimierz Widenka, Tomasz Hirnle, Marek Deja, Krzysztof Bartuś, Roberto Lorusso, Zdzisław Tobota, Bohdan Maruszewski und 2 weitere

Kardiologia Polska · 2023

DOI: 10.33963/kp.a2023.0137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kardiologia Polska, 2023. Verfasst von Mariusz Kowalewski und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior and Administration, Warszawa, Poland. kowal…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Tricuspid Valve Insufficiency, Mitral Valve Insufficiency, Cardiac Surgical Procedures. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: While tackling moderate tricuspid regurgitation (TR) simultaneously with left-side heart surgery is recommended by the guidelines, the procedure is still seldom performed, especially in the minimally invasive setting. Atrial fibrillation (AF) is a known marker of both mortality and TR progression after mitral valve surgery. AIMS: This study aimed to investigatev the safety of performing tricuspid intervention and minimally invasive mitral valve surgery (MIMVS) in patients with preoperative AF. METHODS: We retrospectively analyzed data from the Polish National Registry of Cardiac Surgery Procedures collected between 2006 and 2021. We included all patients who underwent MIMVS (mini-thoracotomy, totally thoracoscopic, or robotic surgery) and had presented with moderate tricuspid regurgitation and AF preoperatively. The primary endpoint was death from any cause at 30 days and at the longest available follow-up after MIMVS with tricuspid intervention vs. MIMVS alone. We used propensity score (PS) matching to account for baseline differences between groups. RESULTS: We identified 1545 patients with AF undergoing MIMVS, 54.7% were men aged 66.7 (mean [standard deviation, SD], 9.2) years. Of those, 733 (47.4%) underwent concomitant tricuspid valve intervention. At 13 years of follow-up, the addition of tricuspid intervention was associated with 33% higher mortality as compared to MIMVS alone (hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.05-1.69; P = 0.02). PS matching resulted in identifying 565 well-balanced pairs. Concomitant tricuspid intervention did not influence long-term follow-up (HR, 1.01; 95 CI, 0.74-1.38; P = 0.94). CONCLUSIONS: After adjusting for baseline confounders, the addition of tricuspid intervention for moderate tricuspid regurgitation to MIMVS did not increase perioperative mortality nor influence long-term survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationTricuspid Valve InsufficiencyMitral Valve InsufficiencyCardiac Surgical ProceduresHeart Valve Prosthesis ImplantationMaleHumansFemaleMitral ValveRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

atrial fibrillationminimally invasive surgerymitral valvetricuspid valve

Autor:innen und Institutionen

  • Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior and Administration, Warszawa, Poland. kowalewskimariusz@gazeta.pl.
  • Cardio-Thoracic Surgery Department, Heart and Vascular Center, Maastricht University Medical Centre, Maastricht, Netherlands. kowalewskimariusz@gazeta.pl.
  • Thoracic Research Center, Collegium Medicum Nicolaus Copernicus University, Innovative Medical Forum, Bydgoszcz, Poland. kowalewskimariusz@gazeta.pl.
  • Department of Invasive Cardiology, Medical University of Bialystok, Białystok, Poland.
  • Department and Clinic of Cardiac Surgery, Wroclaw Medical University, Wrocław, Poland.
  • Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior and Administration, Warszawa, Poland.

Zitieren

APA

Kowalewski, M., Dąbrowski, E. J., Kuźma, Ł., Jasiński, M., Pasierski, M., Widenka, K., Hirnle, T., Deja, M., Bartuś, K., Lorusso, R., Tobota, Z., Maruszewski, B., Suwalski, P., & Investigators, K. (2023). Tricuspid intervention for less-than-severe regurgitation simultaneously with minimally invasive mitral valve surgery in patients with atrial fibrillation. Kardiologia Polska. https://doi.org/10.33963/kp.a2023.0137

Vancouver

Kowalewski M, Dąbrowski EJ, Kuźma Ł, Jasiński M, Pasierski M, Widenka K, et al. Tricuspid intervention for less-than-severe regurgitation simultaneously with minimally invasive mitral valve surgery in patients with atrial fibrillation. Kardiologia Polska. 2023. doi:10.33963/kp.a2023.0137

BibTeX
@article{Kowalewski2023,
  author = {Kowalewski, Mariusz and Dąbrowski, Emil Julian and Kuźma, Łukasz and Jasiński, Marek and Pasierski, Michał and Widenka, Kazimierz and Hirnle, Tomasz and Deja, Marek and Bartuś, Krzysztof and Lorusso, Roberto and Tobota, Zdzisław and Maruszewski, Bohdan and Suwalski, Piotr and Investigators, Krok},
  title = {Tricuspid intervention for less-than-severe regurgitation simultaneously with minimally invasive mitral valve surgery in patients with atrial fibrillation},
  journal = {Kardiologia Polska},
  year = {2023},
  doi = {10.33963/kp.a2023.0137}
}
Kostenlos starten →